Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
112.26
+0.11 (0.10%)
At close: Mar 28, 2025, 4:00 PM
109.35
-2.91 (-2.59%)
After-hours: Mar 28, 2025, 6:21 PM EDT
Zimmer Biomet Holdings Employees
Zimmer Biomet Holdings had 17,000 employees as of December 31, 2024. The number of employees decreased by 1,000 or -5.56% compared to the previous year.
Employees
17,000
Change (1Y)
-1,000
Growth (1Y)
-5.56%
Revenue / Employee
$451,682
Profits / Employee
$53,165
Market Cap
22.35B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 17,000 | -1,000 | -5.56% |
Dec 31, 2023 | 18,000 | 0 | - |
Dec 31, 2022 | 18,000 | -1,500 | -7.69% |
Dec 31, 2021 | 19,500 | -500 | -2.50% |
Dec 31, 2020 | 20,000 | 100 | 0.50% |
Dec 31, 2019 | 19,900 | 900 | 4.74% |
Dec 31, 2018 | 19,000 | 800 | 4.40% |
Dec 31, 2017 | 18,200 | -300 | -1.62% |
Dec 31, 2016 | 18,500 | 1,000 | 5.71% |
Dec 31, 2015 | 17,500 | 7,500 | 75.00% |
Dec 31, 2014 | 10,000 | 500 | 5.26% |
Dec 31, 2013 | 9,500 | 200 | 2.15% |
Dec 31, 2012 | 9,300 | 600 | 6.90% |
Dec 31, 2011 | 8,700 | -100 | -1.14% |
Dec 31, 2010 | 8,800 | 600 | 7.32% |
Dec 31, 2009 | 8,200 | -300 | -3.53% |
Dec 31, 2008 | 8,500 | 900 | 11.84% |
Dec 31, 2007 | 7,600 | 700 | 10.14% |
Dec 31, 2006 | 6,900 | 200 | 2.99% |
Dec 31, 2005 | 6,700 | 100 | 1.52% |
Dec 31, 2004 | 6,600 | 100 | 1.54% |
Dec 31, 2003 | 6,500 | 2,900 | 80.56% |
Dec 31, 2002 | 3,600 | 200 | 5.88% |
Dec 31, 2001 | 3,400 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ZBH News
- 17 days ago - Paragon 28 Announces Expiration of HSR Act Waiting Period for Pending Acquisition by Zimmer Biomet Under HSR Act - Business Wire
- 18 days ago - Zimmer Biomet Highlights Diverse Portfolio of Orthopedic & Musculoskeletal Innovations at AAOS 2025 Annual Meeting - PRNewsWire
- 21 days ago - Zimmer Biomet Receives FDA Clearance for Persona® Revision SoluTion™ Femur - PRNewsWire
- 22 days ago - Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer - PRNewsWire
- 4 weeks ago - Zimmer Biomet to Present at the 27th Annual Barclays Healthcare Conference - PRNewsWire
- 4 weeks ago - Zimmer Biomet Appoints Jehanzeb Noor as Senior Vice President, Chief Strategy, Innovation and Business Development Officer - PRNewsWire
- 4 weeks ago - Zimmer Biomet Launches You'll Be Back Campaign with Chief Movement Officer Arnold Schwarzenegger - PRNewsWire
- 4 weeks ago - Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2025 - PRNewsWire